Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nike Kwai Cheung Lau, Magdalene Huen Yin Tang, Sau Wah Ng, Yeow Kuan Chong, Sammy Pak Lam Chen, Hencher Han Chih Lee, Chor Kwan Ching & Tony Wing Lai Mak. (2021) Toxicity from illegitimate slimming agents – a 10-year case series at a tertiary toxicology laboratory in Hong Kong. Clinical Toxicology 59:5, pages 426-432.
Read now
Read now
Articles from other publishers (33)
James E Clark & Emily Sirois. (2023) Coercion versus self-selection when treating issues of overfatness: A narrative review. Health Education Journal, pages 001789692311718.
Crossref
Crossref
Awab I. Ali Ibrahim, Brenna MendozaFatima Cody StanfordSonali Malhotra. (2022) Real-World Experience of the Efficacy and Safety of Phentermine Use in Adolescents: A Case Series. Childhood Obesity.
Crossref
Crossref
Antea DeMarsilis, Niyoti Reddy, Chrysoula Boutari, Andreas Filippaios, Elliot Sternthal, Niki Katsiki & Christos Mantzoros. (2022) Pharmacotherapy of type 2 diabetes: An update and future directions. Metabolism 137, pages 155332.
Crossref
Crossref
Dalia M. Mabrouk, Aida I. El Makawy, Kawkab A. Ahmed, Mohamed Fawzy Ramadan & Faten M. Ibrahim. (2022) Topiramate potential neurotoxicity and mitigating role of ginger oil in mice brain. Environmental Science and Pollution Research 29:58, pages 87184-87199.
Crossref
Crossref
Keyi Si, Yang Hu, Molin Wang, Caroline M. Apovian, Jorge E. Chavarro & Qi Sun. (2022) Weight loss strategies, weight change, and type 2 diabetes in US health professionals: A cohort study. PLOS Medicine 19:9, pages e1004094.
Crossref
Crossref
Harold Edward Bays, Ethan Lazarus, Craig Primack & Angela Fitch. (2022) Obesity pillars roundtable: Phentermine – Past, present, and future. Obesity Pillars 3, pages 100024.
Crossref
Crossref
Zozan Guleken & Tayfun Uzbay. (2022) Neurobiological and neuropharmacological aspects of food addiction. Neuroscience & Biobehavioral Reviews 139, pages 104760.
Crossref
Crossref
Jennifer Lynn Ford, Jacqueline G. Gerhart, Andrea N. Edginton, Jack A. Yanovski, Yuen Yi Hon & Daniel Gonzalez. (2022) Physiologically Based Pharmacokinetic Modeling of Metformin in Children and Adolescents With Obesity. The Journal of Clinical Pharmacology 62:8, pages 960-969.
Crossref
Crossref
Harold E. Bays, Angela Fitch, Sandra Christensen, Karli Burridge & Justin Tondt. (2022) Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars 2, pages 100018.
Crossref
Crossref
Dalal Al‐Bazz & John P.H. Wilding. 2022. Clinical Obesity in Adults and Children. Clinical Obesity in Adults and Children
279
296
.
Deepika Sankaran, Satyan Lakshminrusimha & Veena Manja. (2021) Methamphetamine: burden, mechanism and impact on pregnancy, the fetus, and newborn. Journal of Perinatology 42:3, pages 293-299.
Crossref
Crossref
James D. Haddad & Shawn L. Shah. (2022) Medical Management of Obesity as it Affects Reflux. Foregut: The Journal of the American Foregut Society 1:4, pages 328-335.
Crossref
Crossref
James E Clark & Sarah Welch. (2021) Comparing effectiveness of fat burners and thermogenic supplements to diet and exercise for weight loss and cardiometabolic health: Systematic review and meta-analysis. Nutrition and Health 27:4, pages 445-459.
Crossref
Crossref
Amy Beth Ingersoll. (2021) Current Evidence-Based Treatment of Obesity. Nursing Clinics of North America 56:4, pages 495-509.
Crossref
Crossref
Rajveer Shekhawat & Chandi C. Mandal. (2021) Anti-Obesity Medications in Cancer Therapy: A Comprehensive Insight. Current Cancer Drug Targets 21:6, pages 476-494.
Crossref
Crossref
Meetal Mehta, Nawfal W. Istfan & Caroline M. Apovian. (2021) Obesity: Overview of Weight Management. Endocrine Practice 27:6, pages 626-635.
Crossref
Crossref
Marcus May & Stefan Engeli. (2020) Gewichtsänderung als unerwünschte Arzneimittelwirkung. Adipositas - Ursachen, Folgeerkrankungen, Therapie 14:03, pages 133-139.
Crossref
Crossref
Ali Naveed, Larabe Farrukh, Muhammad Khawar Sana, Bazigh Naveed & Fawad Ahmad Randhawa. (2020) Pharmacological Primary Prevention of Diabetes Mellitus Type II: A Narrative Review. Cureus.
Crossref
Crossref
Hanan Khalil, Laura Ellwood, Heidi Lord & Ritin Fernandez. (2020) Pharmacological Treatment for Obesity in Adults: An Umbrella Review. Annals of Pharmacotherapy 54:7, pages 691-705.
Crossref
Crossref
Zhong Li Xue, Adebisi Muslimat Kehinde, Liuyi Liuyi, Salim Mzee Said Abdulraman, Mahmud Abdul Nazif, Kanton Aaron Gia & Mustapha Abdullateef Taiye. (2020) Obesity may increase the prevalence of Parkinson’s Disease (PD) while PD may reduce obesity index in patients. Journal of Neuroscience and Neurological Disorders 4:1, pages 024-028.
Crossref
Crossref
Zheng Guan, Gabriel Jacobs, Hans Pelt, Joop M.A. Van Gerven, Jacobus Burggraaf & Wei Zhao. (2020) PK/PD modeling of 5‐hydroxytryptophan (5‐HTP) challenge test with cortisol measurement in serum and saliva. Pharmacology Research & Perspectives 8:2.
Crossref
Crossref
Rajeev Chawla, SV Madhu, BM Makkar, Sujoy Ghosh, Banshi Saboo & Sanjay Kalra. (2020) RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020. Indian Journal of Endocrinology and Metabolism 24:1, pages 1.
Crossref
Crossref
Kaylee Woodard, Logan Louque & Daniel S. Hsia. (2020) Medications for the treatment of obesity in adolescents. Therapeutic Advances in Endocrinology and Metabolism 11, pages 204201882091878.
Crossref
Crossref
Junyeong Choi, Dongwon Yoon, Minhee Park, Kyung-in Joung & Ju-Young Shin. (2020) Topiramate-related adverse events. Medicine 99:42, pages e22669.
Crossref
Crossref
Rajeev Chawla, S. V. Madhu, B. M. Makkar, Sujoy Ghosh, Banshi Saboo & Sanjay Kalra. (2020) RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020. International Journal of Diabetes in Developing Countries 40:S1, pages 1-122.
Crossref
Crossref
Benjamin J. Seicol, Sebastian Bejarano, Nicholas Behnke & Liang Guo. (2019) Neuromodulation of metabolic functions: from pharmaceuticals to bioelectronics to biocircuits. Journal of Biological Engineering 13:1.
Crossref
Crossref
Stephanie Chen, Samantha Chao, Monica Konerman, Wei Zhang, Huiying Rao, Elizabeth Wu, Andy Lin, Lai Wei & Anna S. Lok. (2019) Survey of Nonalcoholic Fatty Liver Disease Knowledge, Nutrition, and Physical Activity Patterns Among the General Public in Beijing, China. Digestive Diseases and Sciences 64:12, pages 3480-3488.
Crossref
Crossref
Magdalena Gómez-Silva, Everardo Piñeyro-Garza, Rigoberto Vargas-Zapata, María Elena Gamino-Peña, Armando León-García, Mario Bermúdez de León, Adrián Llerena & Rafael B. R. León-Cachón. (2019) Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial. Scientific Reports 9:1.
Crossref
Crossref
Jordan Rosen, Evan Darwin, Sara Moradi Tuchayi, Lilit Garibyan & Gil Yosipovitch. (2019) Skin changes and manifestations associated with the treatment of obesity. Journal of the American Academy of Dermatology 81:5, pages 1059-1069.
Crossref
Crossref
Mary E Ritchey, Abenah Harding, Shannon Hunter, Craig Peterson, Philip T Sager, Peter R Kowey, Lan Nguyen, Steven Thomas, Miguel Cainzos-Achirica, Kenneth J Rothman, Elizabeth B Andrews & Mary S Anthony. (2019) Cardiovascular Safety During and After Use of Phentermine and Topiramate. The Journal of Clinical Endocrinology & Metabolism 104:2, pages 513-522.
Crossref
Crossref
Chul Jin Lee, Min-Jeong Kim & Sang Joon An. (2019) Current Treatments on Obesity. Korean Journal of Health Promotion 19:4, pages 171.
Crossref
Crossref
Miriam E. Bocarsly. (2018) Pharmacological Interventions for Obesity: Current and Future Targets. Current Addiction Reports 5:2, pages 202-211.
Crossref
Crossref
Donald E. Greydanus, Marisha Agana, Manmohan K. Kamboj, Saad Shebrain, Neelkamal Soares, Ransome Eke & Dilip R. Patel. (2018) Pediatric obesity: Current concepts. Disease-a-Month 64:4, pages 98-156.
Crossref
Crossref